共 213 条
- [1] Lopez AD(2006)Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data Lancet 367 1747-1757
- [2] Mathers CD(2015)Circulating concentrations of endothelin-1 predict coronary heart disease in women but not in men: a longitudinal observational study in the Vara-Skovde Cohort BMC Cardiovasc Disord 15 146-602.e1
- [3] Ezzati M(2014)National trend in congenital heart disease mortality in china during 2003 to 2010: a population-based study J Thorac Cardiovasc Surg 148 596-2271
- [4] Jamison DT(2015)Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials Lancet 385 2264-1046
- [5] Murray CJ(1994)Genetic susceptibility to death from coronary heart disease in a study of twins N Engl J Med 330 1041-229
- [6] Daka B(2012)Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy Lancet 380 219-138
- [7] Olausson J(2013)Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments Int J Cardiol 168 132-22
- [8] Larsson CA(2012)Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease Lipids Health Dis 11 55-50F
- [9] Hellgren MI(2002)Lp-PLA2: an emerging biomarker of coronary heart disease Expert Rev Mol Diagn 2 17-750
- [10] Råstam L(2008)Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker Am J Cardiol 101 41F-1028